XML 23 R50.htm IDEA: XBRL DOCUMENT v3.20.1
INVESTMENTS (Details Narrative)
 1 Months Ended 6 Months Ended 12 Months Ended
Jul. 16, 2018
USD ($)
shares
Jun. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
$ / shares
shares
Dec. 31, 2019
EUR (€)
shares
Dec. 31, 2019
CAD ($)
shares
Dec. 31, 2018
USD ($)
May 17, 2018
shares
Equity interest acquired, percentage     100.00%        
Cash received with accounting associated     $ 2,000,000        
Marketable securities           $ 2,712,890  
Gain on exchange of investment         (2,500,000)  
Marathon Global Inc [Member]              
Gain on exchange of investment     1,953,000        
Kaneh Bosm Biotechnology Inc [Member] | Share Exchange Agreement [Member]              
Transfer of shares | shares             2,500,000
Kaneh Bosm Biotechnology Inc [Member] | Share Exchange Agreement [Member] | Canadian Securities Exchange [Member]              
Exchange of shares | shares             5,000,000
Share exchange agreement [Member] | ICC [Member]              
Additional shares issued value     33,000        
Equity method investment shares acquired | shares 5,000,000            
Description for ownership percentage The ten million shares of ICC owned by the Company constitute approximately 7% of the 141,219,108 shares of capital stock of KBB then issued and outstanding            
Loss on sale of equity investments     $ 1,528,162        
Additional shares issued | shares     3,000,000        
Equity investment     $ 33,000     2,500,000  
Common stock shares sold during the period | shares     7,000,000 7,000,000 7,000,000    
Proceeds from sold of common shares     $ 1,261,718        
Unrealized loss on exchange of investment           1,545,200  
Unrealized gain net     $ 322,880     $ 2,500,000  
Share exchange agreement [Member] | Marathon Global Inc [Member]              
Shares of Marathon transferred by company to KBB | shares 2,500,000            
Gain on exchange of investment $ 2,092,200            
Distribution and Equity Acquisition Agreement [Member] | Marathon Global Inc [Member]              
Equity interest acquiredpercentage, description     33 1/3% equity ownership interest 33 1/3% equity ownership interest 33 1/3% equity ownership interest 33 1/3% equity ownership interest  
Cash received upon repayment for purchase common stock         $ 2,000,000    
Distribution and Equity Acquisition Agreement [Member] | Marathon Global Inc [Member] | Gross Sales One [Member]              
Cash received upon gross sales         2,750,000    
Gross sales         13,000,000    
Distribution and Equity Acquisition Agreement [Member] | Marathon Global Inc [Member] | Gross Sales [Member]              
Cash received upon gross sales         2,750,000    
Gross sales         $ 6,500,000    
Marketable securities - Divsersa S.A. [Member]              
Closing price of shares | $ / shares     $ 5.01        
Shares issued as marketable securities | shares     40,000        
Marketable securities - National Bank of Greece [Member]              
Closing price of shares | $ / shares     $ 0.34        
Marketable securities     $ 5,651        
Shares issued as marketable securities | shares     16,666        
Cosmo Farmacy LP [Member]              
Cash recognized by acquisition   $ 221,457        
Investement     $ 163,575        
Initial share capital     € 150,000      
Initial share capital increased     500,000      
Pharmacy license value     € 350,000      
Maturity period of license   30 years 30 years 30 years    
Ownership equity   70.00%          
cash contributed to limited partner     € 150,000      
Equity ownership remaining   30.00%